Filing Details
- Accession Number:
- 0000950170-25-096744
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-17 20:51:11
- Reporting Period:
- 2025-07-15
- Filing Date:
- 2025-07-17
- Accepted Time:
- 2025-07-17 20:51:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1712601 | B. Steven Binder | 1 Casper Street Danbury CT 06810 | No | No | No | No |
Transaction Summary
Sold: | 75,367 shares | Avg. Price: $3.94 | Total Value: $296,945.98 |
Number of Shares After Transactions: | 830,508 shares |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Disposition | 2025-07-15 | 19,383 | $3.85 | 905,875 | No | 4 | F | Direct | |
Common Stock, $0.01 Par Value | Disposition | 2025-07-16 | 75,367 | $3.94 | 830,508 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 incident to the vesting of previously reported restricted stock units.
- Transaction occurred pursuant to Rule 10B5-1 Plan established August 16, 2024.
- The weighted average sales price of the reported transaction was $3.94 based on a range of prices between $3.91 and $3.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.